Cleopatra Hospital Group reported a 39.97% year-on-year decline in consolidated net profits for the first half of 2026. Net profit reached EGP 270.723 million for the period. This figure compares to EGP 450.986 million recorded in the first half of 2025. Revenues climbed 27.4% during the same timeframe. Total revenue amounted to EGP 4.309 billion.
Basic and diluted earnings per share dropped to EGP 0.19. This marks a decrease from the EGP 0.31 reported in the previous year. The company joined the EGX 30 Index on September 1, 2026. Five analysts currently maintain a consensus hold rating on the stock. Rising operational expenses and efficiency challenges pressured the bottom line despite significant top-line expansion.